Curaleaf Holdings (CURLF) Liabilities from Discontinued Operations (2020 - 2025)

Curaleaf Holdings (CURLF) recorded quarterly Liabilities from Discontinued Operations of 7073000.0 in Q4 2025, down 20.57% quarter-over-quarter from 8905000.0 in Q4 2024, and down 20.57% on a YoY basis from 8905000.0 in Q4 2024.

Curaleaf Holdings (CURLF) Liabilities from Discontinued Operations (2020 - 2025) Analysis & Trends

Curaleaf Holdings' Liabilities from Discontinued Operations history runs 6 years deep, the most recent figure standing at 7073000.0 for Q4 2025.

  • In Q4 2025, Liabilities from Discontinued Operations fell 20.57% year-over-year to 7073000.0; the TTM figure through Dec 2025 stood at 7073000.0 (down 20.57% YoY), while the FY2025 annual figure was 7073000.0, down 20.57% from the prior year.
  • Liabilities from Discontinued Operations was 7073000.0 for Q4 2025 at Curaleaf Holdings, down from 8905000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 23045000000.0 in Q1 2022 to a low of 1067000.0 in Q3 2024.
  • Historically, Liabilities from Discontinued Operations has averaged 1549350066.67 across 5 years, with a median of 12775000.0 in 2021.
  • The sharpest annual moves came in 2022 and 2024: Liabilities from Discontinued Operations soared 180291.39% in 2022, then sank 95.67% in 2024.
  • A 5-year view of Liabilities from Discontinued Operations shows it stood at 18581000.0 in 2021, then soared by 91.3% to 35545000.0 in 2022, then slumped by 74.19% to 9173000.0 in 2023, then retreated by 2.92% to 8905000.0 in 2024, then slipped by 20.57% to 7073000.0 in 2025.
  • The last three Liabilities from Discontinued Operations figures came in at 7073000.0 (Q4 2025), 8905000.0 (Q4 2024), and 1067000.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Curaleaf Holdings - - 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.07 Mn
Dec 31, 2025 7.07 Mn
Dec 31, 2024 8.91 Mn
Dec 31, 2024 8.91 Mn
Sep 30, 2024 1.07 Mn
Sep 30, 2024 1.07 Mn
Jun 30, 2024 3.00 Mn
Jun 30, 2024 3.00 Mn
Dec 31, 2023 9.17 Mn
Dec 31, 2023 9.17 Mn
Sep 30, 2023 24.62 Mn
Sep 30, 2023 24.62 Mn
Jun 30, 2023 10.51 Mn
Jun 30, 2023 10.51 Mn
Dec 31, 2022 35.55 Mn
Dec 31, 2022 35.55 Mn
Sep 30, 2022 15.83 Mn
Sep 30, 2022 15.83 Mn
Jun 30, 2022 18.85 Mn
Jun 30, 2022 18.85 Mn